atezolizumab
roche
['imvigor130']
building off of excellent preclinical work, presenting interesting posthoc analysis of #imvigor130 - assay details matter, and sp142 may better pick up pd-l1 expression on dcs, which may lead to better predictive capabilities #esmo22 
Oncologist, physician-scientist, Assistant Professor @YaleCancer @YaleMed | cancer immunotherapy, genomics, kidney cancer | tweets ? medical advice.